Product
HEMGENIX
1 clinical trial
1 indication
Indication
Hemophilia BClinical trial
An Observational Post-authorization Long-term Follow-up Study to Characterize the Effectiveness and Safety of HEMGENIX® (Etranacogene Dezaparvovec) in Patients With Hemophilia BStatus: Recruiting, Estimated PCD: 2043-08-01